1. Home
  2. GKOS vs CHRD Comparison

GKOS vs CHRD Comparison

Compare GKOS & CHRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • CHRD
  • Stock Information
  • Founded
  • GKOS 1998
  • CHRD 2007
  • Country
  • GKOS United States
  • CHRD United States
  • Employees
  • GKOS N/A
  • CHRD N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • CHRD Oil & Gas Production
  • Sector
  • GKOS Health Care
  • CHRD Energy
  • Exchange
  • GKOS Nasdaq
  • CHRD Nasdaq
  • Market Cap
  • GKOS 5.1B
  • CHRD 5.5B
  • IPO Year
  • GKOS 2015
  • CHRD 2010
  • Fundamental
  • Price
  • GKOS $89.91
  • CHRD $93.04
  • Analyst Decision
  • GKOS Strong Buy
  • CHRD Buy
  • Analyst Count
  • GKOS 13
  • CHRD 12
  • Target Price
  • GKOS $135.15
  • CHRD $156.17
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • CHRD 772.8K
  • Earning Date
  • GKOS 04-30-2025
  • CHRD 05-06-2025
  • Dividend Yield
  • GKOS N/A
  • CHRD 8.77%
  • EPS Growth
  • GKOS N/A
  • CHRD N/A
  • EPS
  • GKOS N/A
  • CHRD 15.18
  • Revenue
  • GKOS $404,523,000.00
  • CHRD $5,036,741,000.00
  • Revenue This Year
  • GKOS $27.84
  • CHRD N/A
  • Revenue Next Year
  • GKOS $27.88
  • CHRD $0.83
  • P/E Ratio
  • GKOS N/A
  • CHRD $6.16
  • Revenue Growth
  • GKOS 23.92
  • CHRD 31.78
  • 52 Week Low
  • GKOS $77.10
  • CHRD $79.83
  • 52 Week High
  • GKOS $163.71
  • CHRD $188.02
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • CHRD 47.10
  • Support Level
  • GKOS $84.26
  • CHRD $88.35
  • Resistance Level
  • GKOS $92.27
  • CHRD $92.38
  • Average True Range (ATR)
  • GKOS 3.94
  • CHRD 2.95
  • MACD
  • GKOS 0.57
  • CHRD 0.63
  • Stochastic Oscillator
  • GKOS 58.87
  • CHRD 51.82

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CHRD Chord Energy Corporation

Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.

Share on Social Networks: